ATE389181T1 - Organtransplantatenabstossung und verbundene bedingungen - Google Patents

Organtransplantatenabstossung und verbundene bedingungen

Info

Publication number
ATE389181T1
ATE389181T1 AT01953220T AT01953220T ATE389181T1 AT E389181 T1 ATE389181 T1 AT E389181T1 AT 01953220 T AT01953220 T AT 01953220T AT 01953220 T AT01953220 T AT 01953220T AT E389181 T1 ATE389181 T1 AT E389181T1
Authority
AT
Austria
Prior art keywords
transplant rejection
organt
related conditions
chain
rejection
Prior art date
Application number
AT01953220T
Other languages
English (en)
Inventor
Marlene Rose
Michael Dunn
Original Assignee
Imp Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imp Innovations Ltd filed Critical Imp Innovations Ltd
Application granted granted Critical
Publication of ATE389181T1 publication Critical patent/ATE389181T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Rheumatology (AREA)
  • Rehabilitation Therapy (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Paper (AREA)
  • Materials For Medical Uses (AREA)
AT01953220T 2000-07-28 2001-07-30 Organtransplantatenabstossung und verbundene bedingungen ATE389181T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0018614.8A GB0018614D0 (en) 2000-07-28 2000-07-28 Organ transplant rejection and associated conditions

Publications (1)

Publication Number Publication Date
ATE389181T1 true ATE389181T1 (de) 2008-03-15

Family

ID=9896576

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01953220T ATE389181T1 (de) 2000-07-28 2001-07-30 Organtransplantatenabstossung und verbundene bedingungen

Country Status (10)

Country Link
US (1) US7192716B2 (de)
EP (1) EP1366367B1 (de)
AT (1) ATE389181T1 (de)
AU (2) AU7571301A (de)
CA (1) CA2417465C (de)
DE (1) DE60133224T2 (de)
DK (1) DK1366367T3 (de)
ES (1) ES2303834T3 (de)
GB (1) GB0018614D0 (de)
WO (1) WO2002010755A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928136D0 (en) 1999-11-29 2000-01-26 Rose Marlene L Organ rejection and associated conditions
CN102043055B (zh) * 2010-10-27 2014-08-06 上海海洋大学 一种水产品中主要过敏原的快速免疫磁珠层析方法
EP2698636A1 (de) 2012-08-13 2014-02-19 Fundació Institut d'Investigació Biomèdica de Bellvitge Verfahren und Reagenzien zur Vorbeugung und/oder Behandlung von Transplantatabstoßung
KR20160142390A (ko) 2014-04-09 2016-12-12 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 면역평가 및 이식거부의 예측을 위한 단백질 바이오마커
CN110431424B (zh) 2017-03-15 2023-04-07 诺码锐思股份公司 用于确定肾排斥风险的标志物组的用途
CN115060898B (zh) * 2021-07-01 2025-08-12 浙江大学 一种检测抗原肌球蛋白1-IgG抗体的试剂盒

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3805447A1 (de) 1988-02-22 1989-08-31 Drenckhahn Detlef Verfahren und mittel zur bestimmung von nierenschaeden
EP0357856A1 (de) 1988-09-08 1990-03-14 Sansone, Antonio DNS, die für die leichte Kette 2 des menschlichen ventrikularen Myosins kodiert
US5710008B1 (en) * 1990-10-12 1999-09-07 Spectral Diagnostics Inc Method and device for diagnosing and distinguishing chest pain in early onset thereof
US5340721A (en) 1991-07-26 1994-08-23 Board Of Regents, The University Of Texas System Assay for free secretory component and methods for monitoring organ rejection
GB2268935B (en) 1992-06-24 1996-10-23 Nat Heart & Lung Inst Diagnosis of rejection of transplanted organs
US5912121A (en) 1992-12-11 1999-06-15 Bringham And Women's Hospital Methods for detecting mutations associated with hypertrophic cardiomyopathy
DK145393D0 (da) * 1993-12-23 1993-12-23 Stig Haunsoe Proteinmarkoerer til forudsigelse af akut allotransplantatafstoedning
US5534431A (en) 1994-02-28 1996-07-09 The Board Of Regents Of The University Of Nebraska Hybridomas and monoclonal antibodies specific for unique determinants of nephropathy-related immunoglobulin G and complexes thereof
US6197599B1 (en) * 1998-07-30 2001-03-06 Guorong Chin Method to detect proteins
US6476193B1 (en) 1998-10-06 2002-11-05 Curagen Corporation NLK1 protein and NLK1 protein complexes
GB9928136D0 (en) 1999-11-29 2000-01-26 Rose Marlene L Organ rejection and associated conditions

Also Published As

Publication number Publication date
WO2002010755A2 (en) 2002-02-07
AU7571301A (en) 2002-02-13
DK1366367T3 (da) 2008-06-23
WO2002010755A3 (en) 2003-10-09
AU2001275713B2 (en) 2006-08-03
ES2303834T3 (es) 2008-09-01
EP1366367A2 (de) 2003-12-03
US20030175811A1 (en) 2003-09-18
EP1366367B1 (de) 2008-03-12
CA2417465A1 (en) 2002-02-07
DE60133224D1 (de) 2008-04-24
CA2417465C (en) 2010-01-12
GB0018614D0 (en) 2000-09-13
US7192716B2 (en) 2007-03-20
WO2002010755A9 (en) 2005-09-09
DE60133224T2 (de) 2009-03-19

Similar Documents

Publication Publication Date Title
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
DK1409544T3 (da) Humane DR4-antistoffer og anvendelser deraf
DE60324006D1 (de) Damenbinden mit laschen und mitteln zur entlastung von beanspruchungen
DK0922102T3 (da) Receptor-agonister af hepatocyt-vækstfaktor og anvendelser deraf
ATE354655T1 (de) Humane antikörper gegen ctla-4 und deren verwendungen
ATE400289T1 (de) Verwendung vom vaskulären endothelialen wachstumsfaktor 2 (vegf-2)
TR199801390T2 (xx) Tromboz tedavisinde kullan�lacak p�ht�la�may� �nleyici maddeler
ATE280181T1 (de) Künstliche peptide mit oberflächenaktivität und ihre verwendung zur herstellung von künstlichen tensiden
DE69916828D1 (de) Pyrazoline, ihre herstellung und verwendung als medikamente
DK1181319T3 (da) Kimære DR4-antistoffer og anvendelser deraf
DE59712094D1 (de) Mittel zur herstellung von aquarien- und gartenteichwasser und verwendung davon
ATE389181T1 (de) Organtransplantatenabstossung und verbundene bedingungen
EP1487854A4 (de) Neue isoformen des gefässendothel-zellwachstumshemmers
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
DE59701378D1 (de) Neue lederbehandlungsmittel, verfahren zu ihrer herstellung und ihre verwendung bei der herstellung foggingarmer leder
DE60143818D1 (de) Alpha-fetoprotein-peptide und ihre verwendung
TR200400639T4 (tr) Donmaya-karşı proteinler, bunların üretimleri ve kullanımları
DE59808298D1 (de) Verwendung von verbesserten, internen trennmitteln für die herstellung von durch glasfasern und/oder naturfasern verstärkten polyurethanformkörpern
BR0309122A (pt) Plantas com morfogênese melhorada e método para sua construção
DE60228468D1 (de) Kunstzähne und ihre herstellung
PT1064018E (pt) Utilizacao de dominios isolados de colagenio de tipo iv para modificar interaccoes celulares e teciduais
DE69800966D1 (de) Spermaverdünner der natives phosphocaseinat oder beta lactoglobulin enthält, verfahren zu seiner herstellung und seine verwendungen
CY1106740T1 (el) Παραλλαγες του μειζονος αλλεργιογονου par j 2 του φυτου περδικακι
DE60316316D1 (de) Verbesserung bei fässern zur behandlung von fellen, häuten und leder
DK1119242T3 (da) System af vægtlegemer

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1366367

Country of ref document: EP